Parvalbumin Promoter Methylation Altered in Major Depressive Disorder

Int J Med Sci. 2019 Aug 14;16(9):1207-1214. doi: 10.7150/ijms.36131. eCollection 2019.

Abstract

Aims: To determine the extent of DNA methylation of parvalbumin gene (PVALB) promoter in major depressive disorder (MDD) patients with and without suicide attempt in comparison with healthy controls. Methods: The extracted DNA from dried blood spots of MDD patients (n = 92) including non-suicidal MDD and suicidal-MDD subgroups (n = 45 and n = 47, respectively) and age-matched control subjects (n = 95) was used for DNA methylation analysis at four CpG sites in the promoter sequence of PVALB by pyrosequencing. Results: The PVALB methylation was significantly increased at CpG2 and decreased at CpG4 in the MDD group compared to the control group, while there was no difference between non-suicidal MDD and suicidal-MDD subgroups. A significant inverse correlation of severity of MDD was indicated only for CpG4. Conclusion: This study provides the first evidence of abnormalities of PVALB promoter methylation in MDD and its correlation with MDD severity indicating a role for epigenetics in this psychiatric disorder.

Keywords: DNA methylation; major depressive disorder; parvalbumin; pyrosequencing; suicide attempt.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Case-Control Studies
  • DNA Methylation*
  • Depressive Disorder, Major / genetics*
  • Depressive Disorder, Major / psychology
  • Epigenesis, Genetic
  • Female
  • Humans
  • Long Interspersed Nucleotide Elements
  • Male
  • Middle Aged
  • Parvalbumins / genetics*
  • Promoter Regions, Genetic*
  • Suicide, Attempted
  • Young Adult

Substances

  • PVALB protein, human
  • Parvalbumins